IL2 and acute myeloid leukemia: Consistently, the proportion of inhibitory CD4+CD25+ T-regulatory (Treg) cells has been found markedly increased in AML-patient-derived peripheral blood samples and these Treg cells were shown to reduce T-cell proliferation and cytokine production, i.e., IFN-gamma and interleukin (IL)-2 [30,38,39].